Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04025814 · ClinicalTrials.gov registry record · NA

dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
73
Enrollment target
1
Study location

NCT04025814: Completed NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of California, San Francisco.

NCT04025814 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by University of California, San Francisco. The registered enrollment target is 73 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04025814, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustained use of evidence-based parenting strategies.

Primary Outcome

10-item sale for assessing technology product usability

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE CaregiverAssist
  • BEHAVIORAL Behavioral Parent Training (CLS Parent Group)

Study Locations (1)

California

  • HALP Clinic, Children's Center at Langley Porter, UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2020-08-01
Est. Completion 2024-11-12
Phase NA
University of California, San Francisco

1,713 total trials

What the finished NCT04025814 record still lists

NCT04025814 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which CaregiverAssist is the first listed.

NCT04025814 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04025814 about?

NCT04025814 is a clinical study titled "dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD". This study aims to develop, refine and preliminarily test a novel and scalable digital health solution designed to address parent adherence barriers in daily life contexts and increase parent's sustained use of evidence-based parenting strategies.

What is the current status of trial NCT04025814?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2020-08-01. Estimated completion is 2024-11-12.

What conditions does trial NCT04025814 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT04025814?

The interventions under investigation include: CaregiverAssist (DEVICE), Behavioral Parent Training (CLS Parent Group) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04025814?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04025814 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04025814's enrollment target sits among peer trials

73 51st of 102 higher than 52 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03661307 · 73 participants · Phase 1

    Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

  • NCT05386108 · 73 participants · Phase 1

    Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • NCT05961592 · 73 participants · Phase 1

    R-2487 in Patients With Rheumatoid Arthritis

  • NCT06150664 · 73 participants · Phase 1

    A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04025814, the US trial registry maintained by the National Library of Medicine. NCT04025814 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.